State Street Corp Forma Therapeutics Holdings, Inc. Transaction History

State Street Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	BUY	$7.12 - $20.24 $214,639 - $610,155	30,146 Added 3.27%	951,871 $19 Million
Q2 2022 Aug 15, 2022	SELL	$5.1 - $10.0 $9.59 Million - $18.8 Million	-1,880,424 Reduced 67.11%	921,725 $6.35 Million
Q1 2022 May 16, 2022	BUY	$8.34 - $14.69 $8.34 Million - $14.7 Million	999,479 Added 55.44%	2,802,149 $26.1 Million
Q4 2021 Feb 14, 2022	BUY	$13.6 - $24.89 $4.69 Million - $8.58 Million	344,670 Added 23.64%	1,802,670 $25.6 Million
Q3 2021 Nov 15, 2021	SELL	$21.22 - $25.7 $15.2 Million - $18.4 Million	-716,375 Reduced 32.95%	1,458,000 $33.8 Million
Q2 2021 Aug 16, 2021	BUY	$22.86 - $30.95 $6.92 Million - $9.37 Million	302,780 Added 16.18%	2,174,375 $54.1 Million
Q1 2021 May 17, 2021	BUY	$24.58 - $42.82 $25 Million - $43.5 Million	1,016,220 Added 118.8%	1,871,595 $52.4 Million
Q4 2020 Feb 16, 2021	BUY	$34.9 - $51.08 $22.5 Million - $32.9 Million	645,047 Added 306.69%	855,375 $29.9 Million
Q3 2020 Nov 10, 2020	BUY	$32.95 - $50.25 $6.93 Million - $10.6 Million	210,328 New	210,328 $10.5 Million

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.